Dow Up0.08% Nasdaq Down0.30%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
7.29 Up 0.05(0.69%) Sep 19, 4:00PM EDT
|After Hours : 7.29 0.00 (0.00%) Sep 19, 4:40PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Assets
Current Assets
Cash And Cash Equivalents65,187  37,814  50,454  
Short Term Investments90,116  72,238   -  
Net Receivables5,857  9,267  7,426  
Inventory -   -   -  
Other Current Assets5,484  8,982  7,709  
Total Current Assets 166,644   128,301   65,589  
Long Term Investments -   -   -  
Property Plant and Equipment13,364  6,297  6,206  
Goodwill3,605  3,605  3,605  
Intangible Assets1,845  2,165  2,485  
Accumulated Amortization -   -   -  
Other Assets6,959  8,606  7,414  
Deferred Long Term Asset Charges -   -   -  
Total Assets 192,417   148,974   85,299  
Liabilities
Current Liabilities
Accounts Payable38,814  25,644  18,266  
Short/Current Long Term Debt8,248  2,373  48  
Other Current Liabilities10,672  10,503  7,837  
Total Current Liabilities 57,734   38,520   26,151  
Long Term Debt103,427  37,482   -  
Other Liabilities1,200  1,200  1,516  
Deferred Long Term Liability Charges73,184  78,192  79,323  
Minority Interest337  97   -  
Negative Goodwill -   -   -  
Total Liabilities 235,882   155,491   106,990  
Stockholders' Equity
Misc Stocks Options Warrants -   -  268,799  
Redeemable Preferred Stock -   -   -  
Preferred Stock -   -   -  
Common Stock1,025  958  118  
Retained Earnings(572,245)(442,116)(350,839)
Treasury Stock -   -   -  
Capital Surplus527,779  434,679  60,231  
Other Stockholder Equity(24)(38) -  
Total Stockholder Equity (43,465) (6,517) (290,490)
Net Tangible Assets (48,915) (12,287) (296,580)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.